Lambda Variant PCR Kit: What Labs Should Verify Before Procurement

SARS-CoV-2 Variant Lambda (C.37) Real Time PCR Kit

The SARS-CoV-2 Variant Lambda (C.37) Real Time PCR Kit is a Bioperfectus laboratory product for molecular diagnostic testing related to the Lambda variant. Its product page identifies the regulatory status as CE-IVD, and it is supplied for trained personnel following instructions and local requirements.

The stated targets are ORF1a/b plus F490S and T76I in the S gene. The listed limit of detection is 500 copies/mL, and the accepted sample types are nasopharyngeal swabs, throat swabs, and sputum specimens.

The page also reports 100% coincidence with internal positive and negative references. That figure is a manufacturer-provided claim, so laboratories should review the associated validation documentation rather than treat it as an independent finding.

Procurement checks should cover local recognition of CE-IVD status, extraction and PCR instrument compatibility, package size, shelf life, and cold-chain requirements. The supplied information does not specify instrument platforms or kit configuration.

Scientific China lists sourcing, minimum order quantity, and logistics support. Buyers should confirm availability, delivery terms, and a formal quotation before committing to a variant-specific inventory position.

Variant-specific assays can become obsolete as circulating lineages shift. The operational question is not whether the kit exists, but whether its target panel and documentation fit the laboratory’s current testing strategy.

Why it matters:
Confirm regulatory acceptance, target relevance, and workflow compatibility before ordering. A variant-specific kit is only as useful as the surveillance need it addresses.

View Product →